Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience.

ABSTRACT:

SUBMITTER: Jimenez-Britez G 

PROVIDER: S-EPMC7836292 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature